Cardiac patients
Research conducted at Novartis Pharmaceuticals Corporation in Basel, Switzerland has found a consistent association between elevated lipoprotein(a) [Lp(a)] levels and increased cardiovascular risk in Japanese patients. The study, recently published in JACC Asia, involved a systematic review of existing literature to investigate the relationship between Lp(a) levels
Cardiovascular diseases
Researchers at Soochow University in China have investigated the relationship between alcohol consumption and dementia risk, using data from the UK Biobank cohort. The study, published in the European Journal of Epidemiology, found that low-to-moderate drinking was associated with a lower risk of incident dementia, regardless of cardiovascular disease risk,
Cardiovascular diseases
People with HIV are at high risk of recurrent cardiovascular events, particularly those with atherosclerotic cardiovascular disease (ASCVD). Researchers from the University Medical Center Utrecht studied a large cohort of individuals with HIV and controls without HIV to estimate the 10-year recurrence risk and the potential benefits of guideline-recommended interventions.
Antiretroviral agents
Researchers from Mangosuthu University of Technology have shed light on the persistent inflammation in HIV-positive individuals, despite antiretroviral therapy (ART). The study, published in the African Journal of Laboratory Medicine, analyzed retrospective laboratory results from 275 individuals, aged 0-39 years, treated at a tertiary hospital in South Africa. The findings
Cardiovascular diseases
Research conducted in China's Guangdong province has shed light on the relationship between dynapenic abdominal obesity (DAO) and cardiovascular diseases (CVD). The study, led by Xiangming Hu of the Southern Medical University, analyzed data from the China Health and Retirement Longitudinal Study, which spanned from 2011 to 2018.
Cardiovascular diseases
A study published in BMC Public Health highlights the alarming rise of cardiovascular disease (CVD) among Indians with type 2 diabetes mellitus (T2DM). The research, conducted in Gujarat, India, compared the effectiveness of two cardiovascular risk assessment tools, QRISK3 and Lipid Association of India (LAI) risk scores, in a community-based
Cardiovascular diseases
A recent study published in Age and Ageing has found that cocoa extract supplements rich in cocoa flavanols may reduce inflammation in older adults, which could help explain their heart-protective effects. The study, a part of the large-scale, randomized, double-blind, placebo-controlled COcoa Supplement and Multivitamin Outcomes Study (COSMOS), analyzed blood
Anti-obesity agents
Novo Nordisk, the Danish drug giant, is aggressively expanding its presence in the Indian market with its blockbuster weight-loss drug Wegovy (semaglutide). The company aims to hit $1 billion (Rs 8,600 crore) in sales with Wegovy in five to seven years, making it a game-changer in the prescription brand
Cardiac patients
A large-scale trial has shown that the medication semaglutide can significantly reduce the risk of major adverse cardiovascular events and heart failure in patients with overweight or obesity and heart failure. The study, conducted in 41 countries, involved 17,604 patients who were randomly assigned to receive semaglutide or a
